Inhibition of the response to thermal injury by oral proteolytic enzyme.
D000284:Administration, Oral; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D002056:Burns / Q000188:drug therapy*; D002918:Chymotrypsin / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D006801:Humans; D008297:Male; D010919:Placebos; D012881:Skin Temperature / Q000187:drug effects*; D014357:Trypsin / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D004338:Drug Combinations; D010919:Placebos; D002918:Chymotrypsin; D014357:Trypsin